Product Introduction:
Gmm V 0.2/500/2 Mg Tablet is a combination of Voglibose (0.2 mg), Metformin (500 mg), and Glimepiride (2 mg). It works through complementary mechanisms to reduce blood glucose levels in patients with type 2 diabetes when diet and exercise alone are insufficient.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps control both fasting and postprandial blood sugar levels
-
Prevents diabetes-related complications
Benefits:
-
Controls blood sugar through multiple pathways
-
Improves insulin sensitivity and reduces liver glucose production
-
Reduces intestinal absorption of carbohydrates
-
Decreases risk of long-term diabetic complications
Composition:
-
Voglibose 0.2 mg
-
Metformin Hydrochloride 500 mg
-
Glimepiride 2 mg
Side Effects:
-
Hypoglycemia (especially if dosage is not managed properly)
-
Nausea, vomiting, or diarrhea
-
Abdominal discomfort
-
Flatulence or bloating
-
Dizziness or headache (occasionally)
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood glucose levels regularly
-
Do not skip meals while on this medication
-
Avoid alcohol to prevent lactic acidosis (Metformin-related)
-
Consult doctor if you have kidney, liver, or heart conditions
-
Not recommended during pregnancy or breastfeeding without medical advice
